A detailed history of Northstar Asset Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Northstar Asset Management Inc holds 2,165 shares of MRK stock, worth $245,857. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,165
Previous 2,266 4.46%
Holding current value
$245,857
Previous $298,000 10.07%
% of portfolio
0.07%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$123.8 - $132.96 $12,503 - $13,428
-101 Reduced 4.46%
2,165 $268,000
Q1 2024

Aug 12, 2024

BUY
$113.24 - $131.95 $11,437 - $13,326
101 Added 4.67%
2,266 $299 Million
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $22,648 - $26,389
-200 Reduced 8.11%
2,266 $298,000
Q2 2023

Aug 03, 2023

SELL
$108.61 - $118.38 $48,222 - $52,560
-444 Reduced 15.26%
2,466 $285 Million
Q1 2023

Apr 27, 2023

SELL
$102.94 - $114.86 $10,294 - $11,486
-100 Reduced 3.32%
2,910 $310 Million
Q4 2022

Feb 08, 2023

BUY
$87.44 - $112.11 $263,194 - $337,451
3,010 New
3,010 $334 Million
Q3 2022

May 15, 2023

SELL
$84.53 - $94.96 $1,267 - $1,424
-15 Reduced 0.48%
3,124 $269 Million
Q2 2022

May 15, 2023

BUY
$83.49 - $94.64 $18,785 - $21,294
225 Added 7.72%
3,139 $286 Million
Q1 2022

May 15, 2023

SELL
$73.51 - $82.4 $88,212 - $98,880
-1,200 Reduced 29.17%
2,914 $239 Million
Q4 2021

May 15, 2023

SELL
$72.28 - $90.54 $61,438 - $76,959
-850 Reduced 17.12%
4,114 $315 Million
Q3 2021

May 15, 2023

SELL
$71.68 - $78.83 $207,872 - $228,607
-2,900 Reduced 36.88%
4,964 $373 Million
Q2 2021

May 15, 2023

BUY
$70.31 - $77.77 $204,883 - $226,621
2,914 Added 58.87%
7,864 $612 Million
Q1 2021

May 15, 2023

BUY
$68.86 - $81.11 $140,474 - $165,464
2,040 Added 70.1%
4,950 $382 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Northstar Asset Management Inc Portfolio

Follow Northstar Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northstar Asset Management Inc with notifications on news.